Lirimilast

Overview

Lirimilast (BAY 19-8004) is a potent, selective and orally active phosphodiesterase-4 ( PDE4 ) inhibitor with an IC 50 value of 49 nM. Lirimilast can be used for the treatment of asthma or chronic obstructive pulmonary disease (COPD). Lirimilast has potently anti-inflammatory properties.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Phosphodiesterase (PDE)

Product Information

• Catalog No.: HY-19672
• CAS No.: 329306-27-6
• Molecular Formula: C17H12Cl2N2O6S
• Molecular Weight: 443.26
• Purity: 98.69%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source